Abstract
Freeze-drying is a popular method to prepare pharmaceutical formulations containing structurally complex active ingredients and drug delivery system carriers. The solidification performed at lower temperature significantly improves storage stability of proteins, peptides, antibiotics, vaccines, and liposomes, which are marginally stable in aqueous solutions. Individual components of the freeze-drying process (freezing, primary drying, secondary drying), however, expose proteins to various stresses. Certain excipients, including disaccharides (e.g., sucrose, trehalose) and amino acids, can be added to protect the proteins and supramolecular drug delivery systems against physical stress associated with freezing and storage by substituting the molecular interactions provided by water molecules. Some excipients embed the active ingredients in glass-state solids with low molecular mobility, thereby reducing chemical reactivity. Thus, the use of appropriate excipients and process control is important to protect proteins during freeze-drying. This chapter describes the applications of freeze-drying in the pharmaceutical production process, mainly focusing on formulation and process optimization for protein therapeutics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADC:
-
Antibody–drug conjugate
- API:
-
Active pharmaceutical ingredient
- BSE:
-
Bovine spongiform encephalopathy
- CJD:
-
Creutzfeldt-Jakob disease
- DDS:
-
Drug delivery system
- DSC:
-
Differential scanning calorimeter
- LiCl:
-
Lithium chloride
- MS:
-
Mass spectrometry
- NaCl:
-
Sodium chloride
- OD:
-
Orally disintegrating
- PAT:
-
Process analytical technology
- PVP:
-
Polyvinylpyrrolidone
- T g :
-
Glass transition temperature
- T g′ :
-
Glass transition temperature of maximally freeze-concentrated solute
References
Allison SD, Manning MC, Randolph TW, Middleton K, Davis A, Carpenter JF (2000) Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran. J Pharm Sci 89:199–214
Anchordoquy TJ, Izutsu KI, Randolph TW, Carpenter JF (2001) Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying. Arch Biochem Biophys 390:35–41
Arakawa T, Prestrelski SJ, Kenney WC, Carpenter JF (2001) Factors affecting short-term and long-term stabilities of proteins. Adv Drug Deliv Rev 46:307–326
Beech KE, Biddlecombe JG, van der Walle CF, Stevens LA, Rigby SP, Burley JC, Allen S (2015) Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations. Eur J Pharm Biopharm 96:247–254
Bellavia G, Paccou L, Guinet Y, Hedoux A (2014) How does glycerol enhance the bioprotective properties of trehalose? Insight from protein-solvent dynamics. J Phys Chem B 118:8928–8934
Cao W, Xie Y, Krishnan S, Lin H, Ricci M (2013) Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization. Pharm Res 30:131–139
Carpenter JF, Chang BS, Garzon-Rodriguez W, Randolph TW (2002) Rational design of stable lyophilized protein formulations: theory and practice. Pharm Biotechnol 13:109–133
Chang BS, Patro SY (2004) Freeze-drying process development for protein pharmaceuticals. In: Costantino HR, Pikal MJ (eds) Lyophilization of biopharmaceuticals. American Association of Pharmaceutical Scientists, Arlington, pp 113–138
Chang LL, Pikal MJ (2009) Mechanisms of protein stabilization in the solid state. J Pharm Sci 98:2886–2908
Chen C, Han D, Cai C, Tang X (2010) An overview of liposome lyophilization and its future potential. J Control Release 142:299–311
Clavaud M, Roggo Y, Dégardin K, Sacré PY, Hubert P, Ziemons E (2016) Moisture content determination in an antibody-drug conjugate freeze-dried medicine by near-infrared spectroscopy: a case study for release testing. J Pharm Biomed Anal 131:380–390
Cleland JL et al (2001) A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci 90:310–321
Costantino HR, Langer R, Klibanov AM (1994) Moisture-induced aggregation of lyophilized insulin. Pharm Res 11:21–29
Costantino HR, Schwendeman SP, Langer R, Klibanov AM (1998) Deterioration of lyophilized pharmaceutical proteins. Biochemistry 63:357–363
Devineni D, Gonschorek C, Cicerone MT, Xu Y, Carpenter JF, Randolph TW (2014) Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface. Eur J Pharm Biopharm 88:332–341
Ejima D, Tsumoto K, Fukada H, Yumioka R, Nagase K, Arakawa T, Philo JS (2007) Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins 66:954–962
Fonte P, Reis S, Sarmento B (2016) Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery. J Control Release 225:75–86
Forney-Stevens KM, Bogner RH, Pikal MJ (2016) Addition of amino acids to further stabilize lyophilized sucrose-based protein formulations: I. Screening of 15 amino acids in two model proteins. J Pharm Sci 105:697–704
Furman JL, Chiu M, Hunter MJ (2015) Early engineering approaches to improve peptide developability and manufacturability. AAPS J 17:111–120
Geidobler R, Winter G (2013) Controlled ice nucleation in the field of freeze-drying: fundamentals and technology review. Eur J Pharm Biopharm 85:214–222
Goshima H, Do G, Nakagawa K (2016a) Impact of ice morphology on design space of pharmaceutical freeze-drying. J Pharm Sci 105:1920–1933
Goshima H, Forney-Stevens KM, Liu M, Qian KK, Tyagi M, Cicerone MT, Pikal MJ (2016b) Addition of monovalent electrolytes to improve storage stability of freeze-dried protein formulations. J Pharm Sci 105:530–541
Hansen LJJ, Daoussi R, Vervaet C, Remon JP, De Beer TRM (2015) Freeze-drying of live virus vaccines: a review. Vaccine 33:5507–5519
Iyer LK, Sacha GA, Moorthy BS, Nail SL, Topp EM (2016) Process and formulation effects on protein structure in lyophilized solids using mass spectrometric methods. J Pharm Sci 105:1684–1692
Izutsu K, Kojima S (2000) Freeze-concentration separates proteins and polymer excipients into different amorphous phases. Pharm Res 17:1316–1322
Izutsu K, Yoshioka S, Terao T (1993) Decreased protein-stabilizing effects of cryoprotectants due to crystallization. Pharm Res 10:1232–1237
Izutsu K, Fujimaki Y, Kuwabara A, Aoyagi N (2005) Effect of counterions on the physical properties of l-arginine in frozen solutions and freeze-dried solids. Int J Pharm 301:161–169
Jena S, Suryanarayanan R, Aksan A (2016) Mutual influence of mannitol and trehalose on crystallization behavior in frozen solutions. Pharm Res 33:1413–1425
Kasper JC, Winter G, Friess W (2013) Recent advances and further challenges in lyophilization. Eur J Pharm Biopharm 85:162–169
Kawai H, Sakurai M, Inoue Y, Chûjô R, Kobayashi S (1992) Hydration of oligosaccharides: anomalous hydration ability of trehalose. Cryobiology 29:599–606
Kishore D, Kundu S, Kayastha AM (2012) Thermal, chemical and pH induced denaturation of a multimeric β-galactosidase reveals multiple unfolding pathways. PLoS One 7:e50380
Korpus C, Pikal M, Friess W (2016) Heat transfer analysis of an optimized, flexible holder system for freeze-drying in dual chamber cartridges using different state-of-the-art PAT tools. J Pharm Sci 105:3304–3313
Lai MC, Topp EM (1999) Solid-state chemical stability of proteins and peptides. J Pharm Sci 88:489–500
Lai F, Pini E, Corrias F, Perricci J, Manconi M, Fadda AM, Sinico C (2014) Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Int J Pharm 467:27–33
Lim JY, Lim DG, Kim KH, Park SK, Jeong SH (2018) Effects of annealing on the physical properties of therapeutic proteins during freeze drying process. Int J Biol Macromol 107(Pt A):730–740
Liu B, Zhou X (2015) Freeze-drying of proteins. Methods Mol Biol 1257:459–476
Manning MC, Patel K, Borchardt RT (1989) Stability of protein pharmaceuticals. Pharm Res 6:903–918
Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WL (2017) How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions. Eur J Pharm Biopharm 114:288–295
Moussa EM, Panchal JP, Moorthy BS, Blum JS, Joubert MK, Narhi LO, Topp EM (2016) Immunogenicity of therapeutic protein aggregates. J Pharm Sci 105:417–430
Murase N, Franks F (1989) Salt precipitation during the freeze-concentration of phosphate buffer solutions. Biophys Chem 34:293–300
Nail SL, Jiang S, Chongprasert S, Knopp SA (2002) Fundamentals of freeze-drying. Pharm Biotechnol 14:281–360
Pansare SK, Patel SM (2016) Practical considerations for determination of glass transition temperature of a maximally freeze concentrated solution. AAPS PharmSciTech 17:805–819
Patel SM, Pikal M (2009) Process analytical technologies (PAT) in freeze-drying of parenteral products. Pharm Dev Technol 14:567–587
Patel SM et al (2017) Lyophilized drug product cake appearance: what is acceptable? J Pharm Sci 106:1706–1721
Peters BH, Staels L, Rantanen J, Molnár F, De Beer T, Lehto VP, Ketolainen J (2016) Effects of cooling rate in microscale and pilot scale freeze-drying – variations in excipient polymorphs and protein secondary structure. Eur J Pharm Sci 95:72–81
Pikal-Cleland KA, Cleland JL, Anchordoquy TJ, Carpenter JF (2002) Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. J Pharm Sci 91:1969–1979
Privalov PL (1990) Cold denaturation of proteins. Crit Rev Biochem Mol Biol 25:281–305
Remmele RL, Krishnan S, Callahan WJ (2012) Development of stable lyophilized protein drug products. Curr Pharm Biotechnol 13:471–496
Richardson JM, Lemaire SD, Jacquot JP, Makhatadze GI (2000) Difference in the mechanisms of the cold and heat induced unfolding of thioredoxin h from Chlamydomonas reinhardtii: spectroscopic and calorimetric studies. Biochemistry 39:11154–11162
Shieh IC, Patel AR (2015) Predicting the agitation-induced aggregation of monoclonal antibodies using surface tensiometry. Mol Pharm 12:3184–3193
Shire SJ, Shahrokh Z, Liu J (2004) Challenges in the development of high protein concentration formulations. J Pharm Sci 93:1390–1402
Stärtzel P (2016) The application of amino acids in freeze dried protein formulations. PDA J Pharm Sci Technol:pii
Strambini GB, Gonnelli M (2007) Protein stability in ice. Biophys J 92:2131–2138
Sundaramurthi P, Suryanarayanan R (2010) Influence of crystallizing and non-crystallizing cosolutes on trehalose crystallization during freeze-drying. Pharm Res 27:2384–2393
Sylvester B, Porfire A, Achim M, Rus L, Tomuţă I (2018) A step forward towards the development of stable freeze-dried liposomes: a quality by design approach (QbD). Drug Dev Ind Pharm 44:385–397
Tonnis WF, Mensink MA, de Jager A, van der Voort Maarschalk K, Frijlink HW, Hinrichs WL (2015) Size and molecular flexibility of sugars determine the storage stability of freeze-dried proteins. Mol Pharm 12:684–694
Twomey A, Kurata K, Nagare Y, Takamatsu H, Aksan A (2015) Microheterogeneity in frozen protein solutions. Int J Pharm 487:91–100
Wang W (2000) Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203:1–60
Zbacnik TJ et al (2017) Role of buffers in protein formulations. J Pharm Sci 106:713–733
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Izutsu, Ki. (2018). Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations. In: Iwaya-Inoue, M., Sakurai, M., Uemura, M. (eds) Survival Strategies in Extreme Cold and Desiccation. Advances in Experimental Medicine and Biology, vol 1081. Springer, Singapore. https://doi.org/10.1007/978-981-13-1244-1_20
Download citation
DOI: https://doi.org/10.1007/978-981-13-1244-1_20
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1243-4
Online ISBN: 978-981-13-1244-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)